Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies

Emma J Petrie1,2, Richard W Birkinshaw1,2, Akiko Koide3,4

  • 1Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.

Insights

Synthetic binding proteins called monobodies block necroptosis by preventing the MLKL protein from reaching cell membranes. This discovery reveals a new checkpoint in necroptosis signaling critical for cell death.

Area of Science:

  • Cell biology
  • Molecular biology
  • Immunology

Background:

  • Necroptosis is a regulated cell death pathway involved in host defense and inflammatory diseases.
  • Activation of necroptosis involves phosphorylation of the Mixed Lineage Kinase Domain-Like (MLKL) pseudokinase by RIPK3.
  • The exact control points within necroptosis signaling remain incompletely understood.

Purpose of the Study:

  • To develop novel tools to investigate necroptosis signaling.
  • To identify key regulatory steps in the necroptosis pathway.
  • To elucidate the function of the MLKL N-terminal "killer" domain.

Main Methods:

  • Development of high-affinity monobodies targeting the human MLKL N-terminal four-helix bundle (4HB) domain.
  • Expression of monobodies as genetically encoded reagents in cells.
  • Biochemical assays to assess MLKL recruitment, phosphorylation, oligomerization, and membrane translocation.
  • X-ray crystallography to determine the structural basis of monobody binding.
  • Mutational analysis to assess the role of the identified binding site in necroptosis.

Main Results:

  • Monobodies were generated that bind human MLKL's 4HB domain with nanomolar affinity.
  • Genetically encoded monobodies effectively inhibited necroptotic cell death.
  • Monobodies blocked MLKL translocation to cellular membranes but did not impede its recruitment to the necrosome, phosphorylation by RIPK3, or oligomerization.
  • X-ray crystallography identified a critical binding site on the MLKL α4 helix within the 4HB domain.
  • Mutational analysis confirmed the α4 helix is essential for necroptosis signaling.

Conclusions:

  • The α4 helix of the MLKL 4HB domain is a crucial regulatory site in necroptosis.
  • This site is distinct from known phospholipid-binding sites and is implicated in recruiting adaptors for membrane translocation.
  • Monobodies targeting this site represent potent inhibitors of necroptosis and valuable research tools.